A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)
Clinical trial NCT05753865 · UNKNOWN
Trial details
- NCT number
- NCT05753865
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2024-09-01
- Enrollment
- 454
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.